World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

A CASE REPORT ON KSHEERABALA TAILA MATRABASTI IN UDAVARTINI YONIVYAPAT (PRIMARY DYSMENORRHEA)

Lakshmi.V.S* and Asokan.V

ABSTRACT

Pain is one among the prime cause for medical intervention as the word ‘Roga’ (disease) indicates its nature. Dysmenorrhoea1,2 is an disease entity characterized by painful menstruation which is a common gynecological condition that affects approximately 50% of menstruating women, hindering their daily routines3. The disease pathology may incorporate primary as well as secondary dysmenorrhoea. The present case report about an unmarried girl aged 21 years diagnosed as Udavartini Yonivyapat based on clinical symptomatology and VAS scale for objective pain grading was selected and intervened with Matrabasthi with Ksheerabala taila.The treatment was selected for the Vatashamaka, Yoni shula Prashaman, properties of the drugs. The dose was 70 ml per day and the duration of treatment was for 7 days each cycle for two consecutive cycles after the cessation of menstrual bleeding. Results were assessed according to a specially prepared grading system for pain and associated symptoms like Praseka, Chardi,Atisara, and Tamodarshana. Significant improvement was seen in symptoms. There was complete remission of symptoms in consideration of the cardinal symptoms of the disease, while there was marked improvement in the associated symptoms. During the follow up of month,there was no recurrence in the symptoms. The study suggests that Matrabasti is a cost effective, simple and less invasive treatment for relieving the symptoms of primary dysmenorrhea. Further observations in this regard will help to develop definitve treatments for Udavartini Yoni Vyapat through Ayurveda and recommending that more research can be done to confirm the findings of this study.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR